Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 1.00 |
| ▸ | PPARG | P37231 | 8/20 | 1.00 |
| ▸ | F7 | P08709 | 7/20 | 1.00 |
| ▸ | F3 | P13726 | 7/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 6/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 5/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23698169 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698171 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698132 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698219 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698246 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698137 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698164 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698135 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698134 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23698248 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108713059-A | VCN enhancer compositions and methods of use thereof | 蓝鸟生物公司 | 2018-10-26 | — | — | CN | claimed |
| EP-4654815-A1 | UNSATURATED ALDEHYDES VIA RICE BIOTRANSFORMATION | Symrise AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| WO-2024156880-A1 | UNSATURATED ALDEHYDES VIA RICE BIOTRANSFORMATION | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | disclosed |
| WO-2024156360-A1 | UNSATURATED ALDEHYDES VIA RICE BIOTRANSFORMATION | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | disclosed |
| WO-2023075489-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC SYNDROME-RELATED DISEASES, COMPRISING, AS ACTIVE INGREDIENT, DENDROPANAX TRIFIDUS SAP EXTRACT OR COMPOUND DERIVED THEREFROM | 국제뇌교육종합대학원대학교 산학협력단 | 2023-05-04 | — | — | WO | disclosed |
| US-20230097753-A1 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES AND USE AS BIOMARKERS | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2023-03-30 | — | — | US | disclosed |
| EP-4098649-A2 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES OF SAME AND USE AS BIOMARKERS | Universitat de les Illes Balears (ES) | 2022-12-07 | — | — | EP | disclosed |
| CN-115052852-A | Alpha-hydroxylated fatty acid metabolites, medical uses thereof, and uses as biomarkers | 巴利阿里群岛大学 | 2022-09-13 | — | — | CN | disclosed |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2022-04-21 | — | — | US | disclosed |
| EP-3973972-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11207388-B2 | Multi-supplement compositions | MELALEUCA, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| EP-3240555-B1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA INC (US) | 2021-08-04 | — | — | EP | disclosed |
| CN-108713059-A | VCN enhancer compositions and methods of use thereof | 蓝鸟生物公司 | 2018-10-26 | — | — | CN | disclosed |
| CN-108220246-A | For improving the compound of viral transduction | 蓝鸟生物公司 | 2018-06-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207388-B2 | Multi-supplement compositions | SLC5A6, FABP2, GLS2 | ALDH1A1 2819/4885PPARG 44/4885F7 1163/4885 |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | ALDH1A1 2819/4885PPARG 44/4885F7 1163/4885 |
| US-20230097753-A1 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES AND USE AS BIOMARKERS | FABP1, CYP27A1, FABP2 | ALDH1A1 129/4885PPARG 115/4885F7 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.